ducovest

IMO:NYE-Imperial Oil Ltd (USD)

COMMON STOCK | Oil & Gas Integrated |

Last Closing

USD 69.63

Change

0.00 (0.00)%

Market Cap

USD 36.82B

Volume

0.19M

Analyst Target

USD 32.51
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-04 )

Largest Industry Peers for Oil & Gas Integrated

Symbol Name Price(Change) Market Cap
XOM Exxon Mobil Corp

N/A

 USD 508.57B
CVX Chevron Corp

N/A

 USD 286.59B
SHEL Shell PLC ADR

N/A

 USD 227.04B
TTE TotalEnergies SE ADR

N/A

 USD 153.76B
BP BP PLC ADR

N/A

 USD 103.65B
PBR Petroleo Brasileiro Petrobras ..

N/A

 USD 93.43B
PBR-A Petróleo Brasileiro S.A. - Pe..

N/A

 USD 92.92B
EQNR Equinor ASA ADR

N/A

 USD 77.57B
E Eni SpA ADR

N/A

 USD 49.66B
SU Suncor Energy Inc

N/A

 USD 48.96B

ETFs Containing IMO

ZEO:CA BMO Equal Weight Oil & Ga.. 9.32 % 0.61 %

N/A

 CAD 0.22B
ENCC:CA Global X Canadian Oil and.. 7.16 % 0.00 %

N/A

 CAD 0.34B
XEG:CA iShares S&P/TSX Capped En.. 5.08 % 0.61 %

N/A

 CAD 1.65B
EIPX First Trust Exchange-Trad.. 4.25 % 0.00 %

N/A

 USD 0.28B
FYEM:F Fidelity UCITS ICAV - Eme.. 3.23 % 0.00 %

N/A

 USD 0.09B
FYEQ:F Fidelity UCITS ICAV - Eme.. 3.23 % 0.00 %

N/A

 USD 0.09B
FEMC:SW Fidelity Emerging Markets.. 3.23 % 0.00 %

N/A

 USD 0.09B
FEMQ:LSE Fidelity Emerging Markets.. 2.40 % 0.00 %

N/A

 USD 0.10B
FEMI:LSE Fidelity Emerging Markets.. 2.40 % 0.00 %

N/A

 USD 0.01B
FEMD:LSE Fidelity Emerging Markets.. 2.40 % 0.00 %

N/A

 USD 0.09B
FEME:LSE Fidelity Emerging Markets.. 2.40 % 0.00 %

N/A

 USD 0.09B
EYLD 1.66 % 0.00 %

N/A

 N/A
DGS WisdomTree Emerging Marke.. 1.17 % 0.63 %

N/A

 USD 2.43B
JLES:LSE 0.89 % 0.00 %

N/A

 N/A
JLSP:LSE 0.89 % 0.00 %

N/A

 N/A
JPQE:F 0.89 % 0.00 %

N/A

 N/A
JLEE:XETRA 0.89 % 0.00 %

N/A

 N/A
JPQE:XETRA 0.89 % 0.00 %

N/A

 N/A
HEE:CA 0.00 % 0.84 %

N/A

 N/A
ZFN:CA BMO SIA Focused North Ame.. 0.00 % 0.00 %

N/A

 CAD 0.16B
DGRC:CA CI WisdomTree Canada Qual.. 0.00 % 0.24 %

N/A

 CAD 0.79B

Market Performance

  Market Performance vs. Industry/Classification (Oil & Gas Integrated) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.75% 94% A 90% A-
Dividend Return 1.55% 7% C- 42% F
Total Return 23.30% 94% A 90% A-
Trailing 12 Months  
Capital Gain 41.81% 94% A 92% A
Dividend Return 3.29% 14% F 47% F
Total Return 45.10% 100% F 92% A
Trailing 5 Years  
Capital Gain 153.29% 100% F 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 153.29% 100% F 92% A
Average Annual (5 Year Horizon)  
Capital Gain 39.76% 88% B+ 93% A
Dividend Return 43.11% 81% B- 93% A
Total Return 3.35% 21% F 65% D
Risk Return Profile  
Volatility (Standard Deviation) 52.20% 31% F 17% F
Risk Adjusted Return 82.58% 88% B+ 94% A
Market Capitalization 36.82B 38% F 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.